Keyword: parnell

Sydney, Australia's business district.

High-flying Parnell dips on 2015 results and 2016 guidance

Last year, Aussie transplant Parnell Pharmaceuticals enjoyed strong demand in the U.S. for its products aimed at companion and food animals, driving its sales for the year up 58% to AU$13.2 million ($9.4 million), the company announced Feb. 24. It told investors to expect revenues to grow between 50% and 70% this year to at least $14 million.
Closeup of stock prices

Parnell shares advance on strong Q3 revenue growth

Shares of Parnell Pharmaceuticals were up 9% in morning trading to $3.68 on Wednesday, after the company announced that its sales in the third quarter more than doubled to AU$3.6 million ($2.6 million). In the first 9 months of the year, sales grew 55% to AU$8.5 million ($6.1 million) and the company halved its net loss to AU$5.4 million ($3.9 million).